Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Density"" wg kryterium: Temat


Tytuł :
[Progress of change in bone mineral density after knee arthroplasty].
Autorzy :
Wei W; Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P.R.China.
Wu Y; Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P.R.China.
Zeng Y; Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P.R.China.
Shen B; Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P.R.China.
Pokaż więcej
Źródło :
Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery [Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi] 2021 Jan 15; Vol. 35 (1), pp. 124-129.
Typ publikacji :
Journal Article
MeSH Terms :
Arthroplasty, Replacement, Knee*/adverse effects
Bone Density Conservation Agents*/therapeutic use
Bone Resorption*/etiology
Bone Resorption*/prevention & control
Bone Density ; Humans ; Tibia/surgery
Czasopismo naukowe
Tytuł :
Rationale for Bone Health Optimization in Patients Undergoing Orthopaedic Surgery.
Autorzy :
Anderson PA
Dimar JR
Lane JM
Lehman RA Jr
Pokaż więcej
Źródło :
Instructional course lectures [Instr Course Lect] 2021; Vol. 70, pp. 355-366.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Density Conservation Agents*
Fractures, Bone*/etiology
Fractures, Bone*/prevention & control
Fractures, Bone*/surgery
Orthopedic Procedures*/adverse effects
Orthopedics*
Osteoporosis*
Bone Density ; Humans
Czasopismo naukowe
Tytuł :
Effects of Bisphosphonates on Osteoporosis Induced by Duchenne Muscular Dystrophy: A Prospective Study.
Autorzy :
Zheng WB; From the (1)Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, and the.
Dai Y; Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Hu J; From the (1)Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, and the.
Zhao DC; From the (1)Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, and the.
Wang O; From the (1)Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, and the.
Jiang Y; From the (1)Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, and the.
Xia WB; From the (1)Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, and the.
Xing XP; From the (1)Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, and the.
Li M; From the (1)Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, and the. Electronic address: .
Pokaż więcej
Źródło :
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2020 Dec; Vol. 26 (12), pp. 1477-1485.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Density Conservation Agents*/therapeutic use
Muscular Dystrophy, Duchenne*/complications
Muscular Dystrophy, Duchenne*/drug therapy
Osteoporosis*/chemically induced
Osteoporosis*/drug therapy
Osteoporosis, Postmenopausal*
Alendronate ; Bone Density ; Child ; Diphosphonates/therapeutic use ; Female ; Humans ; Imidazoles/therapeutic use ; Prospective Studies
Czasopismo naukowe
Tytuł :
Treatment of high fracture risk patients in routine clinical practice.
Autorzy :
Lesnyak O; North West State Medical University named after I.I.Mechnikov, St. Petersburg, Russia. .; Saint-Petersburg Municipal Clinical Rheumatology Hospital No. 25, St. Petersburg, Russia. .
Gladkova E; North West State Medical University named after I.I.Mechnikov, St. Petersburg, Russia.; Saint-Petersburg Municipal Clinical Rheumatology Hospital No. 25, St. Petersburg, Russia.
Aleksandrov N; Lilly Pharma LLC, Moscow, Russia.
Belaya Z; National Medical Research Center of Endocrinology, Moscow, Russia.
Belova K; Yaroslavl State Medical University, Yaroslavl, Russia.
Bezlyudnaya N; Federal Center of Traumatology, Orthopedics and Endoprosthesis Replacement, Cheboksary, Russia.
Dobrovolskaya O; Research Institute of Rheumatology named after V.A. Nasonova, Moscow, Russia.
Dreval A; Moscow Regional Research and Clinical Institute named after M.F. Vladimirsky, Moscow, Russia.
Ershova O; Yaroslavl State Medical University, Yaroslavl, Russia.
Grebennikova T; National Medical Research Center of Endocrinology, Moscow, Russia.
Kryukova I; Moscow Regional Research and Clinical Institute named after M.F. Vladimirsky, Moscow, Russia.
Mazurenko S; St Petersburg State University, St. Petersburg, Russia.
Priymak D; Lilly Pharma LLC, Moscow, Russia.
Rozhinskaya L; National Medical Research Center of Endocrinology, Moscow, Russia.
Samigullina R; North West State Medical University named after I.I.Mechnikov, St. Petersburg, Russia.
Solodovnikov A; Ural State Medical University, Yekaterinburg, Russia.
Toroptsova N; Research Institute of Rheumatology named after V.A. Nasonova, Moscow, Russia.
Pokaż więcej
Źródło :
Archives of osteoporosis [Arch Osteoporos] 2020 Nov 20; Vol. 15 (1), pp. 184. Date of Electronic Publication: 2020 Nov 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Bone Density Conservation Agents*/therapeutic use
Osteoporosis, Postmenopausal*
Osteoporotic Fractures*/drug therapy
Osteoporotic Fractures*/epidemiology
Osteoporotic Fractures*/prevention & control
Spinal Fractures*/epidemiology
Spinal Fractures*/prevention & control
Adult ; Aged ; Aged, 80 and over ; Bone Density ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Teriparatide/therapeutic use
Czasopismo naukowe
Tytuł :
LRP6 lets Merlin go in times of nutrient scarcity.
Autorzy :
Wong KKL; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.; Centre for Cell Biology, Development and Disease, Simon Fraser University, Burnaby, BC, Canada.
Verheyen EM; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.; Centre for Cell Biology, Development and Disease, Simon Fraser University, Burnaby, BC, Canada.
Pokaż więcej
Źródło :
EMBO reports [EMBO Rep] 2020 Sep 03; Vol. 21 (9), pp. e51358. Date of Electronic Publication: 2020 Aug 20.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Low Density Lipoprotein Receptor-Related Protein-6*/genetics
Neurofibromin 2*/genetics
Neurofibromin 2*/metabolism
Low Density Lipoprotein Receptor-Related Protein-1 ; Nutrients ; Signal Transduction
Czasopismo naukowe
Tytuł :
Romosozumab: A Review in Postmenopausal Osteoporosis.
Autorzy :
Paik J; Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. .
Scott LJ; Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand.
Pokaż więcej
Źródło :
Drugs & aging [Drugs Aging] 2020 Nov; Vol. 37 (11), pp. 845-855.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antibodies, Monoclonal/*therapeutic use
Bone Density/*drug effects
Osteoporosis, Postmenopausal/*drug therapy
Alendronate/administration & dosage ; Alendronate/therapeutic use ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/pharmacokinetics ; Bone Density Conservation Agents/administration & dosage ; Bone Density Conservation Agents/therapeutic use ; Clinical Trials, Phase III as Topic ; Female ; Fractures, Bone/epidemiology ; Fractures, Bone/prevention & control ; Humans ; Osteogenesis/drug effects ; Teriparatide/administration & dosage ; Teriparatide/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Impact of Bone Mineral Density on the Incidence of Age-Related Vertebral Fragility Fracture.
Autorzy :
Lee J; Department of Orthopaedic Surgery, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Chang G; Department of Orthopaedic Surgery, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Kang H; Department of Anesthesiology and Pain Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Ham DW; Department of Orthopaedic Surgery, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Lee JS; Department of Orthopaedic Surgery, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Jung HS; Department of Orthopaedic Surgery, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Song KS; Department of Orthopaedic Surgery, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea. .
Pokaż więcej
Źródło :
Journal of Korean medical science [J Korean Med Sci] 2020 May 04; Vol. 35 (17), pp. e116. Date of Electronic Publication: 2020 May 04.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Density*
Spinal Fractures/*diagnosis
Age Factors ; Aged ; Aged, 80 and over ; Body Mass Index ; Bone Density Conservation Agents/therapeutic use ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Odds Ratio ; Osteoporosis/complications ; Osteoporosis/drug therapy ; Osteoporosis/pathology ; Republic of Korea/epidemiology ; Retrospective Studies ; Sex Factors ; Spinal Fractures/epidemiology ; Spinal Fractures/etiology
Czasopismo naukowe
Tytuł :
Anabolic Therapy and Optimal Treatment Sequences for Patients With Osteoporosis at High Risk for Fracture.
Autorzy :
Cosman F; From the Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.. Electronic address: .
Pokaż więcej
Źródło :
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2020 Jul; Vol. 26 (7), pp. 777-786. Date of Electronic Publication: 2020 Nov 24.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Bone Density Conservation Agents*/therapeutic use
Fractures, Bone*/epidemiology
Fractures, Bone*/etiology
Fractures, Bone*/prevention & control
Osteoporosis*/drug therapy
Osteoporosis, Postmenopausal*
Bone Density ; Female ; Humans ; Teriparatide/therapeutic use
Czasopismo naukowe
Tytuł :
Eldecalcitol is superior to alfacalcidol in maintaining bone mineral density in glucocorticoid-induced osteoporosis patients (e-GLORIA).
Autorzy :
Matsumoto T; Fujii Memorial Institute of Medical Sciences, Tokushima University, Tokushima, 770-8530, Japan. .
Yamamoto K; Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.
Takeuchi T; Division of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.
Tanaka Y; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan.
Tanaka S; Department of Orthopaedic Surgery, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Nakano T; Tamana Central Hospital, Tamana, Kumamoto, Japan.
Ito M; The Open University of Japan, Nagasaki, Nagasaki, Japan.
Tomomitsu T; Department of Radiology, Kawasaki Medical School, Kurashiki, Okayama, Japan.
Hirakawa A; Department of Biostatistics and Bioinformatics, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Soen S; Department of Orthopaedic Surgery and Rheumatology, Kindai University Nara Hospital, Ikoma, Nara, Japan.
Pokaż więcej
Źródło :
Journal of bone and mineral metabolism [J Bone Miner Metab] 2020 Jul; Vol. 38 (4), pp. 522-532. Date of Electronic Publication: 2020 Mar 05.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Bone Density*/drug effects
Glucocorticoids/*adverse effects
Hydroxycholecalciferols/*therapeutic use
Osteoporosis/*drug therapy
Osteoporosis/*physiopathology
Vitamin D/*analogs & derivatives
Biomarkers/metabolism ; Bone Density Conservation Agents/therapeutic use ; Bone Remodeling/drug effects ; Female ; Femur Neck/drug effects ; Femur Neck/physiopathology ; Hip/physiopathology ; Humans ; Hydroxycholecalciferols/adverse effects ; Hydroxycholecalciferols/pharmacology ; Kaplan-Meier Estimate ; Lumbar Vertebrae/drug effects ; Lumbar Vertebrae/physiopathology ; Male ; Middle Aged ; Spinal Fractures/epidemiology ; Vitamin D/adverse effects ; Vitamin D/pharmacology ; Vitamin D/therapeutic use
Czasopismo naukowe
Tytuł :
Aminobisphosphonate-treated ewes as a model of osteonecrosis of the jaw and of dental implant failure.
Autorzy :
Davison MR; School of Dentistry, Rio Negro National University, Río Negro, Argentina.
Lyardet L; School of Dentistry, Rio Negro National University, Río Negro, Argentina.
Preliasco M; School of Dentistry, Rio Negro National University, Río Negro, Argentina.
Yaful G; Veterinary Sciences, Rio Negro National University, Río Negro, Argentina.
Torres P; Veterinary Sciences, Rio Negro National University, Río Negro, Argentina.
Bonanno MS; Metabolic Bone Diseases Laboratory, Immunology, Genetic and Metabolism Institute (INIGEM), School of Pharmacy and Biochemistry, Clinical Hospital 'José de San Martín', National Council for Scientific and Technologic Research (CONICET)/Buenos Aires University (UBA), Buenos Aires, Argentina.
Pellegrini GG; Metabolic Bone Diseases Laboratory, Immunology, Genetic and Metabolism Institute (INIGEM), School of Pharmacy and Biochemistry, Clinical Hospital 'José de San Martín', National Council for Scientific and Technologic Research (CONICET)/Buenos Aires University (UBA), Buenos Aires, Argentina.
Zeni SN; Metabolic Bone Diseases Laboratory, Immunology, Genetic and Metabolism Institute (INIGEM), School of Pharmacy and Biochemistry, Clinical Hospital 'José de San Martín', National Council for Scientific and Technologic Research (CONICET)/Buenos Aires University (UBA), Buenos Aires, Argentina.
Pokaż więcej
Źródło :
Journal of periodontology [J Periodontol] 2020 May; Vol. 91 (5), pp. 628-637. Date of Electronic Publication: 2019 Dec 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Bone Density Conservation Agents*
Dental Implants*
Osteonecrosis*
Animals ; Bone Density ; Diphosphonates ; Female ; Humans ; Imidazoles ; Ovariectomy ; Sheep
Czasopismo naukowe
Tytuł :
[Pain management in osteoporosis].
Autorzy :
Heuchemer L; Zentrum für Seltene Erkrankungen (ZSEB), Universitätsklinikum Bonn, Venusberg-Campus 1, 53127, Bonn, Deutschland.
Emmert D; Zentrum für Seltene Erkrankungen (ZSEB), Universitätsklinikum Bonn, Venusberg-Campus 1, 53127, Bonn, Deutschland.
Bender T; Zentrum für Seltene Erkrankungen (ZSEB), Universitätsklinikum Bonn, Venusberg-Campus 1, 53127, Bonn, Deutschland.
Rasche T; Zentrum für Seltene Erkrankungen (ZSEB), Universitätsklinikum Bonn, Venusberg-Campus 1, 53127, Bonn, Deutschland.
Marinova M; Radiologische Klinik, Universitätsklinikum Bonn, Bonn, Deutschland.
Kasapovic A; Klinik und Poliklinik für Orthopädie und Unfallchirurgie, Universitätsklinikum Bonn, Bonn, Deutschland.
Conrad R; Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie, Universitätsklinikum Bonn, Bonn, Deutschland.
Mücke M; Zentrum für Seltene Erkrankungen (ZSEB), Universitätsklinikum Bonn, Venusberg-Campus 1, 53127, Bonn, Deutschland. .
Pokaż więcej
Transliterated Title :
Schmerztherapie bei Osteoporose.
Źródło :
Der Orthopade [Orthopade] 2020 Apr; Vol. 49 (4), pp. 363-376.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Bone Density Conservation Agents*
Fractures, Bone*/prevention & control
Pain Management*
Osteoporosis/*therapy
Back Pain/drug therapy ; Bone Density ; Calcium/administration & dosage ; Estrogen Replacement Therapy ; Exercise Therapy ; Humans ; Osteoporosis/diagnosis ; Osteoporosis/psychology ; Quality of Life ; Vitamin D/administration & dosage
Czasopismo naukowe
Tytuł :
Which Drug Next? Sequential Therapy for Osteoporosis.
Autorzy :
Lukert BP; Division of Endocrinology, Metabolism & Genetics, Department of Medicine, University of Kansas School of Medicine, Kansas City, Kansas.
Pokaż więcej
Źródło :
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2020 Mar 01; Vol. 105 (3).
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Bone Density Conservation Agents*
Osteoporosis*/drug therapy
Alendronate ; Bone Density ; Denosumab ; Diphosphonates ; Humans ; Teriparatide
Czasopismo naukowe
Tytuł :
Anti-osteoporosis medication treatment pattern after osteoporotic fracture during 2010-2016 in Fujian, China.
Autorzy :
Wang X; NHC Key Lab. of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), Public Health School, Fudan University, Shanghai, 200032, China.; Shanghai Synyi Medical Technology Co., Ltd, 5th Floor, 232 Liangjing Road, Shanghai, China.
Li C; Shanghai Synyi Medical Technology Co., Ltd, 5th Floor, 232 Liangjing Road, Shanghai, China.
He Y; Shanghai Synyi Medical Technology Co., Ltd, 5th Floor, 232 Liangjing Road, Shanghai, China.
Wang T; Shanghai Synyi Medical Technology Co., Ltd, 5th Floor, 232 Liangjing Road, Shanghai, China.
Zhang H; Shanghai Synyi Medical Technology Co., Ltd, 5th Floor, 232 Liangjing Road, Shanghai, China.
Ma Z; Shanghai Synyi Medical Technology Co., Ltd, 5th Floor, 232 Liangjing Road, Shanghai, China.
Ma H; Shanghai Synyi Medical Technology Co., Ltd, 5th Floor, 232 Liangjing Road, Shanghai, China. .; Department of Computer Science, Shanghai Jiao Tong University, Shanghai, 200240, China. .
Zhao H; Shanghai Synyi Medical Technology Co., Ltd, 5th Floor, 232 Liangjing Road, Shanghai, China. .
Pokaż więcej
Źródło :
Archives of osteoporosis [Arch Osteoporos] 2020 Aug 20; Vol. 15 (1), pp. 134. Date of Electronic Publication: 2020 Aug 20.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Density Conservation Agents/*therapeutic use
Calcitonin/*therapeutic use
Diphosphonates/*therapeutic use
Fractures, Bone/*etiology
Osteoporosis/*drug therapy
Osteoporotic Fractures/*drug therapy
Aged ; Aged, 80 and over ; Bone Density/drug effects ; China/epidemiology ; Cohort Studies ; Drug Prescriptions/statistics & numerical data ; Drug Utilization Review ; Electronic Health Records ; Female ; Fractures, Bone/drug therapy ; Hip Fractures/drug therapy ; Hip Fractures/etiology ; Humans ; Male ; Middle Aged ; Osteoporosis/epidemiology ; Osteoporotic Fractures/epidemiology ; Retrospective Studies
Czasopismo naukowe
Tytuł :
The Efficacy and Safety of Bisphosphonates for Osteoporosis in Women Older Than 65 Years: A Meta-Analysis.
Autorzy :
Fan Q; Shanxi Bethune Hospital, Taiyuan, Shanxi Province, China.
Wang J; Changzhi Medical College, Changzhi, Shanxi Province, China.
Pokaż więcej
Źródło :
Current pharmaceutical design [Curr Pharm Des] 2020; Vol. 26 (32), pp. 4022-4030.
Typ publikacji :
Meta-Analysis
MeSH Terms :
Bone Density Conservation Agents*/adverse effects
Osteoporosis*
Aged, 80 and over ; Biomarkers ; Bone Density ; Diphosphonates/adverse effects ; Female ; Humans
Raport
Tytuł :
Reduced Bone Modeling and Unbalanced Bone Remodeling: Targets for Antiresorptive and Anabolic Therapy.
Autorzy :
Ramchand SK; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA. .; Department of Medicine, Endocrine Unit, Austin Hospital, The University of Melbourne, Melbourne, VIC, Australia. .
Seeman E; Department of Medicine, Endocrine Unit, Austin Hospital, The University of Melbourne, Melbourne, VIC, Australia.; Mary MacKillop Institute for Health Research, Australian Catholic University, Fitzroy, VIC, Australia.
Pokaż więcej
Źródło :
Handbook of experimental pharmacology [Handb Exp Pharmacol] 2020; Vol. 262, pp. 423-450.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Density Conservation Agents*
Osteoporosis*
Bone Density/physiology ; Bone Remodeling/physiology ; Bone and Bones ; Humans
Czasopismo naukowe
Tytuł :
[Osteoporosis: long-term treatment versus drug holiday-what is the evidence?]
Autorzy :
Farahmand P; Justus Liebig Universität Gießen, Gießen, Deutschland. .; MVZ für Nieren- und Hochdruckerkrankungen Marburg, Schubertstr. 8, 35043, Marburg, Deutschland. .
Cassens J; Marburger Medizinisches Versorgungszentrum Am Krekel GmbH, Am Krekel 49, 35039, Marburg, Deutschland.
Pokaż więcej
Transliterated Title :
Osteoporose: Dauertherapie versus Therapiepause – Wofür gibt es Evidenz?
Źródło :
Zeitschrift fur Rheumatologie [Z Rheumatol] 2019 Dec; Vol. 78 (10), pp. 904-909.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Density Conservation Agents*/therapeutic use
Osteoporosis*/drug therapy
Bone Density ; Denosumab ; Diphosphonates ; Humans
Czasopismo naukowe
Tytuł :
Comparative effectiveness of alendronate and zoledronic acid on bone mass improvement in transfusion-dependent thalassemia patients.
Autorzy :
Zekavat OR; Hematology Research Centre, Nemazee Hospital, Shiraz University of Medical Sciences, 7193635899, Shiraz, Iran.
Bordbar M; Hematology Research Centre, Nemazee Hospital, Shiraz University of Medical Sciences, 7193635899, Shiraz, Iran.
Haghpanah S; Hematology Research Centre, Nemazee Hospital, Shiraz University of Medical Sciences, 7193635899, Shiraz, Iran.
Saki F; Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Bazrafshan A; Hematology Research Centre, Nemazee Hospital, Shiraz University of Medical Sciences, 7193635899, Shiraz, Iran.
Bozorgi H; Hematology Research Centre, Nemazee Hospital, Shiraz University of Medical Sciences, 7193635899, Shiraz, Iran. .
Pokaż więcej
Źródło :
Journal of bone and mineral metabolism [J Bone Miner Metab] 2019 Nov; Vol. 37 (6), pp. 996-1003. Date of Electronic Publication: 2019 Apr 11.
Typ publikacji :
Clinical Trial; Comparative Study; Journal Article
MeSH Terms :
Blood Transfusion*
Bone Density*/drug effects
Alendronate/*therapeutic use
Bone and Bones/*pathology
Thalassemia/*drug therapy
Zoledronic Acid/*therapeutic use
Absorptiometry, Photon ; Adolescent ; Adult ; Alendronate/adverse effects ; Bone Density Conservation Agents/therapeutic use ; Bone and Bones/drug effects ; Female ; Humans ; Male ; Middle Aged ; Thalassemia/diagnostic imaging ; Young Adult ; Zoledronic Acid/adverse effects
Czasopismo naukowe
Tytuł :
Peri-prosthetic bone mineral density after simultaneous bilateral total knee arthroplasty under oral bisphosphonate therapy - A comparison between mobile- and fixed-bearing prostheses.
Autorzy :
Ueyama H; Department of Orthopedic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno, Osaka, Japan. Electronic address: .
Minoda Y; Department of Orthopedic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno, Osaka, Japan.
Sugama R; Department of Orthopedic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno, Osaka, Japan.
Ohta Y; Department of Orthopedic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno, Osaka, Japan.
Nakamura S; Department of Orthopedic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno, Osaka, Japan.
Takemura S; Department of Orthopedic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno, Osaka, Japan.
Nakamura H; Department of Orthopedic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno, Osaka, Japan.
Pokaż więcej
Źródło :
The Knee [Knee] 2020 Jun; Vol. 27 (3), pp. 767-776. Date of Electronic Publication: 2020 May 28.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Bone Density*
Knee Prosthesis*
Arthroplasty, Replacement, Knee/*instrumentation
Bone Density Conservation Agents/*administration & dosage
Diphosphonates/*administration & dosage
Osteoarthritis, Knee/*surgery
Absorptiometry, Photon ; Administration, Oral ; Aged ; Female ; Femur/surgery ; Humans ; Lumbar Vertebrae ; Male ; Middle Aged ; Postoperative Period ; Prospective Studies ; Prosthesis Design ; Tibia/surgery ; Time Factors
Czasopismo naukowe
Tytuł :
[Osteoporosis].
Autorzy :
Biver E; Service des maladies osseuses, Département de médecine, HUG et Faculté de médecine, 1205 Genève.
Ferrari S; Service des maladies osseuses, Département de médecine, HUG et Faculté de médecine, 1205 Genève.
Pokaż więcej
Transliterated Title :
Ostéoporose.
Źródło :
Revue medicale suisse [Rev Med Suisse] 2020 Jan 15; Vol. 16 (676-7), pp. 78-80.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Density Conservation Agents*/therapeutic use
Bone Remodeling*
Osteoporosis*/drug therapy
Osteoporosis, Postmenopausal*/drug therapy
Bone Density ; Bone and Bones ; Denosumab ; Diphosphonates ; Humans
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies